Ibuprofen and Pseudoephedrine Hydrochloride Tablets
» Ibuprofen and Pseudoephedrine Hydrochloride Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amounts of Ibuprofen (C13H18O2) and Pseudoephedrine Hydrochloride (C10H15NO·HCl).
Packaging and storage— Preserve in tight containers.
USP Reference standards 11
USP Ibuprofen RS Click to View Structure
USP Pseudoephedrine Hydrochloride RS Click to View Structure
Identification—
A: Place a Tablet in a small beaker, crack the Tablet coating, add 10 mL of methanol, and stir by mechanical means for about 10 minutes. Allow to settle, and use the clear supernatant as the Test solution. Prepare a Standard solution in methanol containing about 20 mg of USP Ibuprofen RS and 20J mg of USP Pseudoephedrine Hydrochloride RS per mL, J being the ratio of the labeled amount, in mg, of pseudoephedrine hydrochloride to the labeled amount, in mg, of ibuprofen per Tablet. Separately apply 10 µL each of the Test solution and the Standard solution to a thin-layer chromatographic plate (see Chromatography 621) covered with a 0.25-mm layer of chromatographic silica gel mixture and activated by heating the plate at 105 for about 30 minutes. Place the plate in a chromatographic chamber equilibrated with a solvent system consisting of a mixture of chloroform, methanol, and glacial acetic acid (80:15:5). Develop the chromatograms until the solvent has moved about 10 cm from the origin. Remove the plate from the chromatographic chamber, place it in a chamber containing iodine vapors for about 10 minutes, and examine the chromatograms: the principal spots obtained from the Test solution correspond in RF value and appearance to those obtained from the Standard solution.
B: The retention times of the pseudoephedrine and ibuprofen peaks, relative to that of the butylparaben internal standard peak in the chromatogram of the Assay preparation correspond to those in the chromatogram of the Standard preparation, as obtained in the Assay.
Dissolution 711
Medium: pH 7.2 phosphate buffer (see under Buffers in the section Reagents, Indicators, and Solutions); 900 mL.
Apparatus 2: 50 rpm.
Times: 30 minutes (ibuprofen); 45 minutes (pseudoephedrine hydrochloride).
Procedure for ibuprofen— Determine the amount of ibuprofen (C13H18O2) dissolved from UV absorbances at the wavelength of maximum absorbance at about 224 nm of filtered portions of the solution under test, suitably diluted with Medium, if necessary, in comparison with a Standard solution having a known concentration of USP Ibuprofen RS in the same medium.
Procedure for pseudoephedrine hydrochloride—
mobile phase— Prepare a solution of monobasic potassium phosphate in water containing 500 mg per 1000 mL. Filter through a filter having a porosity of 0.5 µm or finer. Prepare a mixture of this solution and acetonitrile (500:500), and adjust with phosphoric acid to a pH of 3.3 ± 0.1. Make any necessary adjustments (see System Suitability under Chromatography 621). Increasing the concentration of monobasic potassium phosphate or increasing the pH increases the retention time of pseudoephedrine.
standard preparation —Prepare a solution of USP Pseudoephedrine Hydrochloride RS in Dissolution Medium having a known concentration of about P/900 mg per mL, P being the labeled quantity, in mg, of pseudoephedrine hydrochloride per Tablet.
chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 215-nm detector, a guard column containing packing L10, and a 4.6-mm × 25-cm column that contains packing L10. The flow rate is about 1.5 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor for the pseudoephedrine peak is not more than 2.0, and the relative standard deviation for replicate injections is not more than 2.0%.
procedure— Pass a portion of the solution under test through a filter having a porosity of 0.5 µm or finer. Separately inject equal volumes (about 10 µL) of the filtrate and the Standard preparation into the chromatograph, record the chromatograms, and measure the areas for the pseudoephedrine peaks. Calculate the quantity, in mg, of pseudoephedrine hydrochloride (C10H15NO·HCl) dissolved by the formula:
900C(rU / rS)
in which C is the concentration, in mg per mL, of USP Pseudoephedrine Hydrochloride RS in the Standard preparation; and rU and rS are pseudoephedrine peak responses obtained from the solution under test and the Standard preparation, respectively.
Tolerances— Not less than 75% (Q) of the labeled amounts of ibuprofen (C13H18O2) and pseudoephedrine hydrochloride (C10H15NO·HCl) are dissolved in 30 minutes and in 45 minutes, respectively.
Uniformity of dosage units 905
Procedure for content uniformity— Proceed as directed in the Assay, preparing the Assay preparation as follows. Transfer 1 Tablet to a glass-stoppered conical flask, add 10.0 mL of Internal standard solution, and stir with a magnetic stirrer until the Tablet disintegrates. Add 10.0 mL of acetonitrile, stir for about 15 minutes, and filter.
Assay—
Mobile phase— Dissolve 2.5 g of docusate sodium in a mixture of water and acetonitrile (590:410). Add 1.0 mL of phosphoric acid, and adjust with ammonium hydroxide to a pH of 3.2 ± 0.05. Make any necessary adjustments (see System Suitability under Chromatography 621). Decreasing the proportion of docusate sodium increases the resolution between pseudoephedrine and ibuprofen.
Internal standard solution— Prepare a solution of butylparaben in Mobile phase containing about 0.15 mg per mL.
Standard preparation— Prepare a solution in Internal standard solution having known concentrations of about 20 mg of USP Ibuprofen RS and 20J mg of USP Pseudoephedrine Hydrochloride RS per mL, J being the ratio of the labeled amount, in mg, of pseudoephedrine hydrochloride to the labeled amount, in mg, of ibuprofen per Tablet. To the resulting solution add an equal volume of acetonitrile, accurately measured, and mix. Pass through a filter having 0.5 µm porosity or finer, and use the filtrate as the Standard preparation. This solution contains about 10 mg of USP Ibuprofen RS and 10J mg of USP Pseudoephedrine Hydrochloride RS per mL.
Assay preparation— Transfer an accurately counted number of Tablets, equivalent to about 2000 mg of ibuprofen, to a glass-stoppered conical flask, add 100 mL of Internal standard solution, and stir with a magnetic stirrer until the Tablets disintegrate. Add 100 mL of acetonitrile, and mix. Filter through a filter of 0.5 µm porosity or finer, and use the filtrate as the Assay preparation.
Chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 254-nm detector, a guard column that contains packing L1, and a 4.6-mm × 10-cm column that contains 5-µm packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the relative retention times are about 0.55 for butylparaben, 0.7 for pseudoephedrine, and 1.0 for ibuprofen; the resolution, R, between the butylparaben peak and the pseudoephedrine peak and between the pseudoephedrine peak and the ibuprofen peak is not less than 2.0; the tailing factors for the butylparaben peak, the pseudoephedrine peak, and the ibuprofen peak are not more than 3.0; and the relative standard deviation for replicate injections determined from the peak response ratios is not more than 2.0%.
Procedure— Separately inject equal volumes (about 5 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantities, in mg, of ibuprofen (C13H18O2) and of pseudoephedrine hydrochloride (C10H15NO·HCl) in each Tablet taken by the formula:
200(C / N)(RU / RS)
in which C is the concentration, in mg per mL, of USP Ibuprofen RS or USP Pseudoephedrine Hydrochloride RS, as appropriate, in the Standard preparation; N is the number of Tablets taken; and RU and RS are the ratios of the relevant analyte peak response to the butylparaben peak response obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Clydewyn M. Anthony, Ph.D.
Senior Scientific Liaison
1-301-816-8139
(SM22010) Monographs - Small Molecules 2
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison
1-301-816-8106
(GCDF2010) General Chapters - Dosage Forms
USP35–NF30 Page 3473